Author

C. A. Olson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Assay:whole-genome sequencing· 2 Research Focus:cell type annotation· 1 Organism:E. coli· 1 Organism:human· 1

Frequent Co-Authors

A. M. Feist· 2 shared P. R. Spilman· 2 shared P. Soon-Shiong· 2 shared R. Szubin· 2 shared S. Tanaka· 2 shared W. Higashide· 2 shared A. Rice· 1 shared A. Richardson· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. M. Feist

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Heteologous saRNA-Prime, DNA Dual-Antigen-Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies

A. Rice, M. Verma, E. Voigt, P. Battisti, S. Beaver, S. Reed, K. Dinkins, S. Mody, L. Zakin, S. Tanaka, B. Morimoto, W. Higashide, C. A. Olson, E. R. Gabitzsch, J. T. Safrit, , P. Soon-Shiong

This study evaluates heterologous vaccination with two SARS-CoV-2 vaccines in mice, finding enhanced humoral and T-cell responses and broad neutralizing activity against variants.

bioRxiv · Nov 29, 2021 · PreprintImmunology

Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display

S. Tanaka, C. A. Olson, C. O. Barnes, W. Higashide, M. Gonzales, J. Taft, A. Richardson, M. Martin-Fernandez, D. Bogunovic, P. N. P. Gnanapragasam, P. Bjorkman, P. R. Spilman, K. Niazi, S. Rabizadeh, P. Soon-Shiong

This study uses mRNA display to identify and engineer neutralizing antibodies against SARS-CoV-2 variants, revealing binding modes and demonstrating their effectiveness against mutations in the spike protein.

bioRxiv · Sep 14, 2021Immunology

Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus

H. Machado, Y. Seif, G. Sakoulas, C. A. Olson, R. Szubin, B. Palsson, V. Nizet, A. M. Feist

This study identifies media-specific mutational mechanisms of vancomycin resistance in S. aureus using adaptive laboratory evolution and sequencing.

bioRxiv · Jun 7, 2020Microbiology

Adaptive laboratory evolution of Escherichia coli under acid stress

B. Du, C. A. Olson, A. V. Sastry, X. Fang, P. V. Phaneuf, K. Chen, M. Wu, R. Szubin, S. Xu, Y. Gao, Y. Hefner, A. M. Feist, B. O. Palsson

This study evolves E. coli under acid stress and identifies genetic and expression changes that enhance acid tolerance.

bioRxiv · Jun 4, 2019Microbiology